Spanish labs warn 30 per cent of EU-approved rare disease medicines do not reach local market

0
DRUG SHORTAGE: The collective claimed only 61 of the 118 rare disease treatments available in Europe have been approved in Spain. Photo: Shutterstock


A GROUP of Spanish laboratories has warned around 30 per cent of medicines approved for rare diseases by the European Medicines Agency do not make it onto the Spanish market.

The collective claimed only 61 of the 118 rare disease treatments available in Europe have been approved in Spain.

The group also warned: “The current average time [for approving drugs in Spain] is 19 months, well above other European countries.”  It added the time taken before a medicine goes on sale in Spain jumped from 12.4 months between 2002 and 2013, to 14 months in 2014 and 2017.

The association said: “While it is not a significant difference, the data shows that it is necessary to implement new policies to reduce inequality of access.”

LEAVE A COMMENT

Please enter your comment!
Please enter your name here